India CAR T-Cell Immunotherapy Market (2025-2031) | Industry, Value, Competitive Landscape, Share, Forecast, Companies, Segmentation, Growth, Analysis, Trends, Outlook, Size & Revenue

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 India Country Macro Economic Indicators

3.2 India CAR T-Cell Immunotherapy Market Revenues & Volume, 2021 & 2031F

3.3 India CAR T-Cell Immunotherapy Market - Industry Life Cycle

3.4 India CAR T-Cell Immunotherapy Market - Porter's Five Forces

3.5 India CAR T-Cell Immunotherapy Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 India CAR T-Cell Immunotherapy Market Revenues & Volume Share, By Application, 2021 & 2031F

3.7 India CAR T-Cell Immunotherapy Market Revenues & Volume Share, By Target Antigen, 2021 & 2031F

3.8 India CAR T-Cell Immunotherapy Market Revenues & Volume Share, By End Users, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer in India

4.2.2 Growing investments in healthcare infrastructure and research and development

4.2.3 Rising awareness about immunotherapy and its benefits

4.3 Market Restraints

4.3.1 High cost associated with CAR T-cell therapy

4.3.2 Limited accessibility to advanced healthcare facilities in certain regions of India

4.3.3 Regulatory challenges and approval processes for innovative therapies

6.1 India CAR T-Cell Immunotherapy Market, By Product

6.1.1 Overview and Analysis

6.1.2 India CAR T-Cell Immunotherapy Market Revenues & Volume, By Product, 2021- 2031F

6.1.3 India CAR T-Cell Immunotherapy Market Revenues & Volume, By Allogeneic CAR T-Cells, 2021- 2031F

6.1.4 India CAR T-Cell Immunotherapy Market Revenues & Volume, By Autologous CAR T-Cells, 2021- 2031F

6.2 India CAR T-Cell Immunotherapy Market, By Application

6.2.1 Overview and Analysis

6.2.2 India CAR T-Cell Immunotherapy Market Revenues & Volume, By Diffuse Large B-Cell Lymphoma, 2021- 2031F

6.2.3 India CAR T-Cell Immunotherapy Market Revenues & Volume, By Acute Lymphoblastic Leukemia, 2021- 2031F

6.3 India CAR T-Cell Immunotherapy Market, By Target Antigen

6.3.1 Overview and Analysis

6.3.2 India CAR T-Cell Immunotherapy Market Revenues & Volume, By CD19, 2021- 2031F

6.3.3 India CAR T-Cell Immunotherapy Market Revenues & Volume, By CD22, 2021- 2031F

6.4 India CAR T-Cell Immunotherapy Market, By End Users

6.4.1 Overview and Analysis

6.4.2 India CAR T-Cell Immunotherapy Market Revenues & Volume, By Hospital, 2021- 2031F

6.4.3 India CAR T-Cell Immunotherapy Market Revenues & Volume, By Diagnostic Center, 2021- 2031F

7.1 India CAR T-Cell Immunotherapy Market Export to Major Countries

7.2 India CAR T-Cell Immunotherapy Market Imports from Major Countries

8.1 Number of clinical trials and research studies related to CAR T-cell therapy in India

8.2 Adoption rate of immunotherapy treatments in cancer centers

8.3 Number of partnerships and collaborations between pharmaceutical companies and research institutions in the field of CAR T-cell therapy.

9.1 India CAR T-Cell Immunotherapy Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 India CAR T-Cell Immunotherapy Market Opportunity Assessment, By Application, 2021 & 2031F

9.3 India CAR T-Cell Immunotherapy Market Opportunity Assessment, By Target Antigen, 2021 & 2031F

9.4 India CAR T-Cell Immunotherapy Market Opportunity Assessment, By End Users, 2021 & 2031F

10.1 India CAR T-Cell Immunotherapy Market Revenue Share, By Companies, 2024

10.2 India CAR T-Cell Immunotherapy Market Competitive Benchmarking, By Operating and Technical Parameters